Talk:Nuchal scan

Concern over page summary

It occurs to me that the nuchal translucency (NT) scan is not primarily related to chromosomal abnormality screening (unless other risk factors/indicators are present). Instead, it's my understanding that the NT scan is to screen for cardiovascular problems in the fetus, which might or might not be related to a chromosomal abnormality (e.g. trisomy 21). Screening positive for the NT test does not indicate a chromosomal abnormality, though having a chromosomal abnormality is likely to cause screening positive.

I'd like to hear the thoughts of others, prior to editing the page itself. Buzwad (talk) 20:16, 10 March 2015 (UTC)

Plug for Sequenom?

Why is this sentence in the article? "In 2011, Sequenom announced the launch of MaterniT 21, a non-invasive blood test with a high level of accuracy in detecting Down syndrome" It seems a bit spammy to me. Why is there a mention of a branded blood test product within an article about ultrasound scan techniques? But I'm no expert so thought I'd log it here for discussion. 77.99.138.234 (talk) 14:31, 4 February 2014 (UTC)

I understand your comment about "spam", though I think this is a commonly used screening test that can be used once a nuchal translucency screening screens positive. For people in this position, the knowledge of the MaterniT 21 test is useful, and certainly relevant to this page. Buzwad (talk) 20:16, 10 March 2015 (UTC)

Other abnormalities

macrocephaly (n = 1), spina bifida (n = 2), holoprosencephaly (n = 1), Dandy–Walker malformation (n = 1), facial cleft (n = 2), agnathia (n = 1), cystic hygromas (n = 1), cardiac defects (n = 17), pentalogy of Cantrell (n = 1), Ivemark syndrome (n = 1), Toriello–Carey syndrome (n = 1), diaphragmatic hernia (n = 2), esophageal atresia (n = 1), duodenal atresia (n = 1), exomphalos (n = 4), megacystis (n = 3), multicystic kidneys (n = 1), polycystic kidneys (n = 3), amnion rupture sequence (n = 1), body stalk anomaly (n = 2), achondrogenesis (n = 1), achondroplasia (n = 2), campomelic dysplasia (n = 1), ectrodactyly-ectodermal dysplasia–cleft palate syndrome (EEC) (n = 1), fetal akinesia deformation sequence (FADS) (n = 3), syringomyelia (n = 1), kyphosis (n = 1), talipes (n = 1), GM1-gangliosidosis (n = 1), Joubert syndrome (n = 1), Meckel–Gruber syndrome (n = 1), myotonic dystrophy (n = 1), Noonan syndrome (n = 5), spinal muscular atrophy (n = 2), Zellweger syndrome (n = 1) and unspecified syndromes (n = 6). —Preceding unsigned comment added by 99.112.125.218 (talk) 22:09, 9 February 2011 (UTC)

Nuchal fold

There is no mention in this article about what a nuchal fold actually is. — Preceding unsigned comment added by 131.217.255.208 (talk) 00:34, 4 April 2014 (UTC)

Nuchal fold

Nuchal fold=Nuchal translucency. This is untrue: At the end of the second trimester, the nuchal translucency can no longer be seen and instead the nuchal fold is measured. The fold is more focal and at the level of the posterior fossa. This measurement has a higher threshold of normal, although the implications of increased thickness are similar to those of translucency. Look here: http://autoprac.com/nuchal-scan Ana4eva (talk) 09:48, 25 February 2016 (UTC)